SC

Head-to-heads

Why the winner won and the rival didn’t

Each winner next to the company it beat, traced from its first innovation to its moat. Open one to see every step, what the rival did instead, and the sources.

66 head-to-heads

Adobe beat Quark (QuarkXPress)

Quark owned one application, page layout, that printed through Adobe's PostScript and placed images and drawings made in Adobe's tools. Adobe owned the page model and the designers' daily tools, so it could sell layout inside a suite designers already bought, and the trained teams working across that suite stayed.

Affirm beat Afterpay

Afterpay offered four free payments on small baskets, earned part of its income from late fees and sold itself to Block in 2022 as its losses rose. Affirm quoted the full cost of each loan with no late fees, underwrote it in real time for purchases from $50 to five-year loans, became Shopify's and Amazon's lender, and turned that volume into the funding base of a standalone business with 23 million active consumers.

Atlassian beat Rally Software

Rally sold agile management to enterprises through salespeople and coaches at $35 or more per user a month. Atlassian sold Jira online to any team for a few dollars, let outside developers add the agile boards Rally sold, and let practitioners carry it from team to team.

Autodesk beat Intergraph

Intergraph sold turnkey CAD systems whose revenue came from its own computers, sold them directly and wrote its own applications. Autodesk sold drafting software for other makers' PCs through dealers, let outside developers write the specialist applications and trained a workforce in schools, until DWG was the format Intergraph itself had to read.

Block beat PayPal Here (PayPal)

PayPal Here arrived in 2012 with PayPal's brand and a slightly lower rate, but as a reader and an app. Square had already taken on its sellers' risk, removed the other fees and was putting a register and then loans on the same payment flow; PayPal bought iZettle in 2018 and closed Here in the US in 2023.

Certara beat Simulations Plus (GastroPlus)

Simulations Plus launched GastroPlus first, as an absorption tool it sold and steered on its own, and reached the FDA's drug-interaction reviewers only in 2013. Simcyp had drug makers and regulators build its interaction simulator together, appeared in 80.5% of PBPK-backed FDA novel approvals in 2019–23 against 5.2% for GastroPlus, and anchored a company worth $5.15 billion at the end of 2020, when Simulations Plus peaked at $1.43 billion.

Cloudflare beat Akamai

Akamai sold metered delivery to large enterprises and earned more as their traffic grew. Cloudflare gave its network away to the sites Akamai did not pursue, sold the same network's services up-market, and collected free traffic that Akamai's pricing gave it no reason to carry.

Dayforce beat ADP

ADP sold time and payroll as separate products feeding a service bureau, and kept that bureau and its float income until its rebuilt platform reached general availability in 2024. Dayforce calculated pay continuously on one employee record, and Ceridian stopped selling its own bureau in 2012 to sell it.

Epic Systems beat Cerner (Oracle Health)

Cerner built its software department by department and later bought breadth, while Epic put care and billing on one clinician-shaped database and never made an acquisition. Epic's flagship customers, certified staff and exchange protocol then made each new hospital cheaper to run on Epic, and Cerner lost Kaiser, then Mayo, then a stream of merging health systems.

GoodRx beat SingleCare

SingleCare arrived in 2015 with one card and prices it negotiated directly with pharmacy chains, and bought its reach with TV ads and cards in doctors' offices. GoodRx showed every network's price at each nearby pharmacy, let PBMs pay for the prescriptions it sent them, and grew on unpaid referrals into a profitable company valued at $12.7 billion at its 2020 IPO.

Guardant Health beat Foundation Medicine

Foundation Medicine built its testing around tumor tissue and offered blood as a fallback. Guardant made blood the first sample, with a sequencing method accurate enough to trust, built the evidence, coverage and approval that made ordering it routine, sold the resulting data to drug makers, and by 2018 had about three times Foundation's share of liquid biopsy, a lead Foundation now pays patent royalties to compete in.

Hims & Hers beat Ro (Roman)

Ro launched the same service days earlier, raised far more money and was the larger company in 2020. Hims made its subscriptions profitable first, then spent the margin on a louder brand and its own compounding pharmacies, and by 2024 its revenue was about two and a half times Ro's estimate.

HubSpot beat Marketo

Marketo sold marketing automation that ran on top of Salesforce's CRM and moved upmarket to enterprises. HubSpot sold small businesses a complete suite through its own content and agencies, then gave away its own CRM, so the customer records lived in HubSpot.

Klaviyo beat Mailchimp

Mailchimp was a newsletter tool for every small business, organized around lists of subscribers; Klaviyo was a store's customer database that could send email, so abandoned carts, repeat buyers and attributed revenue came standard. When Shopify asked partners to share merchant data, Klaviyo agreed and Mailchimp left the app store to become an all-in-one suite for all small businesses, and growing online stores consolidated on Klaviyo.

Netflix beat Blockbuster

Blockbuster earned its money from store rentals and late fees, so each move Netflix made, from the fee-free subscription to streaming inside it, asked Blockbuster to give up income it depended on. It tried each one late, pulled back, and was sold by the time Netflix's programming costs were spread over 20 million streaming members.

Okta beat OneLogin

OneLogin had the same product and more apps in 2011, but it sold to smaller companies on a fraction of the money, competed on price, and stalled after its 2017 breach. Okta spent its funding lead on large enterprises and the security record they paid for, then grew inside them until vendors built to its network.

Robinhood beat E*Trade

E*Trade charged about $7 a trade and bought its growth with a $200 million marketing budget. Robinhood let market makers pay for free trades and let customers recruit each other, reached first-time investors E*Trade had never served, and when E*Trade matched the price it gave up about a sixth of its revenue and agreed to sell itself within five months.

ServiceNow beat BMC Remedy

BMC Remedy was a client/server help desk that each customer installed, customized and upgraded. ServiceNow ran one platform itself, used IT service management to win Remedy's enterprise customers, and then put their other departments on the same data model.

Snowflake beat Amazon Redshift

Redshift put the older shared-nothing warehouse on AWS and sold it by the node-hour; Snowflake gave each workload its own compute billed by use, ran on every major cloud and let accounts share live data. By the time Redshift separated storage (2019), shared data (2020) and billed by the second (2022), the workloads had moved.

Spotify beat Rdio

Rdio built the nicer app and charged from the first play, so friends arriving from Facebook met a paywall. Spotify made free listening feel like owning all music, used it to reach far more listeners, and turned their playlists into personal recommendations.

Why Rdio lost →

Teladoc beat Amwell

Amwell sold health systems and plans the software to run telehealth under their own brands, so each client still had to supply doctors and get members to use it. Teladoc sold the finished service for a fee on every covered member, so its revenue grew with contracts rather than calls, and in 2025 it was about ten times Amwell's.

Why Amwell lost →

Tempus beat Foundation Medicine (Roche)

Foundation Medicine sold a reimbursed DNA test, obtained clinical histories through its partnership with Flatiron, and became part of drugmaker Roche in 2018. Tempus ran its own laboratory so every test produced a matched molecular and clinical record, let drugmakers' data fees pay for a broader test, and sold the same growing library to nearly every large drugmaker; it was worth $11.15 billion at the end of 2025, against the $5.3 billion at which Roche valued Foundation in 2018.

Veeva beat Oracle (Siebel)

Oracle sold drug makers the Siebel CRM it sold every industry, with life-sciences features added to a general release that each customer installed, customized and upgraded every few years. Veeva ran one validated pharma-only release for all its customers, took the largest drug makers first, and then sold them regulated-content products that Oracle never built beside its CRM.

Xero beat MYOB

MYOB sold an installed file that the owner and the accountant passed back and forth, and it held its online product back to protect that desktop base. Xero put both on one live ledger fed by the bank, and accountants moved their client books onto it, then kept them there.

Zscaler beat Netskope

Netskope built the same kind of cloud service, so architecture did not separate them. Zscaler reached the web gateway, the largest companies and private access years earlier, and Netskope has been catching up to a larger base ever since.